Tianjin University

its synthetic biology team, led by Academician Yuan Yingjin, co-authored the landmark 2017 Science papers on de novo design and chemical synthesis of four synthetic yeast chromosomes as part of the international Sc2.0 project, and in 2026 published a Nature Methods paper on SynNICE,…

Country
China
research cn
Coverage
CNEUUS
bioinformatics-omics
Regulatorsfdaemanmpa

Verifiable facts

FactValueSource
AffiliationSchool of Synthetic Biology and Biomanufacturing, Tianjin Universitylianpp.com · en.tju.edu.cn
FacilityState Key Laboratory of Synthetic Biologylianpp.com · synbm.tju.edu.cn
FacilityFrontier Science Center for Synthetic Biology (Ministry of Education)lianpp.com
FacilityKey Laboratory of Systems Bioengineering (Ministry of Education)lianpp.com
FacilityNational International Science and Technology Cooperation Base for Synthetic Biotechnologylianpp.com
FacilityNational Engineering Practice Education Centerlianpp.com
Research focussynthetic biology, yeast genome synthesis, DNA information storage, human genome synthesis, and artificial cell designen.tju.edu.cn · global.chinadaily.com.cn · synbm.tju.edu.cn
Principal staffYuan Yingjin (Academician)en.tju.edu.cn · global.chinadaily.com.cn · synbm.tju.edu.cn
Headcount20 senior national-level leading talents, 37 national-level young talents, and 34 national key R&D chief scientists/project leadssynbm.tju.edu.cn
Headcountapproximately 2000 postgraduates trained as of 2022 medium confidenceen.tju.edu.cn
PublicationsTianjin University ranks first globally in the number of synthetic biology research papers in Scopuslianpp.com
GrantMultiple National Key R&D Program projects, National Natural Science Foundation of China (NSFC) major projects, and NSFC Innovation Research Group projectssynbm.tju.edu.cn

Independent sources: en.tju.edu.cn · global.chinadaily.com.cn · lianpp.com · synbm.tju.edu.cn

Technologies
NameClusterRisk
Genomics & DNA designbioinformatics-omicsMedium

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.